Security Snapshot

Shattuck Labs, Inc. - COMMON STOCK (STTK) Institutional Ownership

CUSIP: 82024L103

13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

63

Shares (Excl. Options)

42,026,951

Price

$3.65

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / COMMON STOCK
Symbol
STTK on Nasdaq
Underlying class
Common Stock
Shares outstanding
63,024,709
Price per share
$6.43
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
42,026,951
Total reported value
$153,369,414
% of total 13F portfolios
0%
Share change
+2,987,935
Value change
+$10,969,591
Number of holders
63
Price from insider filings
$6.43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • STTK - Shattuck Labs, Inc. - COMMON STOCK is tracked under CUSIP 82024L103.
  • 63 institutions reported positions in Q4 2025.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 63 to 7 between Q4 2025 and Q1 2026.
  • Reported value moved from $153,369,414 to $17,323,810.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 63 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 82024L103?
CUSIP 82024L103 identifies STTK - Shattuck Labs, Inc. - COMMON STOCK in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Shattuck Labs, Inc. - COMMON STOCK (STTK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 12% $26,914,702 7,373,891 T. Rowe Price Investment Management, Inc. 31 Jan 2026
Prosight Management, LP 9.9% $15,638,344 6,543,240 Prosight Management, LP 30 Sep 2025
Redmile Group, LLC 9.9% -16% $5,422,231 +$617,470 6,379,095 +13% Redmile Group, LLC 25 Aug 2025
ORBIMED ADVISORS LLC 10% $5,107,963 6,306,127 ORBIMED ADVISORS LLC 25 Aug 2025
ADAGE CAPITAL PARTNERS GP, L.L.C. 9.8% $3,740,000 4,675,000 Adage Capital Management, L.P. 31 Dec 2024
VANGUARD GROUP INC 4.5% $1,437,343 2,148,174 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 1.8% $69,509 878,754 BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 63 institutional investors reported holding 42,026,951 shares of Shattuck Labs, Inc. - COMMON STOCK (STTK). This represents 67% of the company’s total 63,024,709 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Shattuck Labs, Inc. - COMMON STOCK (STTK) together control 64% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ORBIMED ADVISORS LLC 10% 6,306,127 0% 0.49% $23,017,364
ADAGE CAPITAL PARTNERS GP, L.L.C. 10% 6,306,127 0% 0.03% $23,017,364
Redmile Group, LLC 8.8% 5,539,724 0% 1.5% $20,219,993
NEXTBio Capital Management LP 5% 3,149,907 0% 6.7% $11,497,161
Prosight Management, LP 3.8% 2,381,502 -56% 1.8% $8,692,482
VANGUARD GROUP INC 3.8% 2,377,746 +12% 0% $8,678,773
PRICE T ROWE ASSOCIATES INC /MD/ 3.1% 1,926,140 0% $7,031,000
CLARK ESTATES INC/NY 2.3% 1,475,648 0% 1.3% $5,386,115
683 Capital Management, LLC 2.2% 1,390,000 -9.3% 0.42% $5,073,500
T. Rowe Price Investment Management, Inc. 2.1% 1,354,761 0% $4,945,000
PINNACLE ASSOCIATES LTD 2.1% 1,350,638 -2.7% 0.06% $4,929,829
BANK OF AMERICA CORP /DE/ 1.8% 1,106,617 -2.2% 0% $4,039,152
Point72 Asset Management, L.P. 1.7% 1,068,231 0.01% $3,899,043
GEODE CAPITAL MANAGEMENT, LLC 0.98% 618,277 +32% 0% $2,257,510
Aberdeen Group plc 0.84% 531,177 +462% 0% $1,938,796
MARSHALL WACE, LLP 0.78% 489,912 -25% 0% $1,788,180
MILLENNIUM MANAGEMENT LLC 0.76% 477,408 -31% 0% $1,742,539
TWO SIGMA INVESTMENTS, LP 0.69% 437,729 +7.1% 0% $1,597,711
BlackRock, Inc. 0.66% 418,529 +1.8% 0% $1,527,631
FMR LLC 0.62% 392,600 +11560% 0% $1,432,990
RENAISSANCE TECHNOLOGIES LLC 0.54% 340,700 +57% 0% $1,243,555
TD Asset Management Inc 0.4% 251,050 0% $916,333
STATE STREET CORP 0.34% 215,418 +22% 0% $786,276
SPHERA FUNDS MANAGEMENT LTD. 0.31% 195,212 0.15% $712,524
TWO SIGMA ADVISERS, LP 0.27% 170,600 +51% 0% $622,690

Institutional Holders of Shattuck Labs, Inc. - COMMON STOCK (STTK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,700,848 $17,323,810 +$4,420,445 $6.43 7
2025 Q4 42,026,951 $153,369,414 +$10,969,591 $3.65 63
2025 Q3 36,387,666 $86,952,184 +$19,208,219 $2.39 55
2025 Q2 28,683,537 $22,652,305 -$2,108,587 $0.79 60
2025 Q1 31,187,405 $29,629,278 -$448,919 $0.95 75
2024 Q4 31,630,688 $38,272,386 -$6,568,042 $1.21 73
2024 Q3 34,264,458 $119,683,589 +$7,366,433 $3.49 75
2024 Q2 34,177,881 $131,925,768 +$4,021,586 $3.86 74
2024 Q1 31,464,617 $281,294,360 +$23,128,263 $8.94 68
2023 Q4 29,145,072 $207,807,364 +$49,347,094 $7.13 57
2023 Q3 19,886,098 $30,226,948 -$551,306 $1.52 39
2023 Q2 20,147,579 $62,861,356 +$1,104,302 $3.12 41
2023 Q1 20,310,220 $59,712,941 -$164,772 $2.94 48
2022 Q4 20,382,396 $46,879,443 -$783,480 $2.30 46
2022 Q3 20,630,140 $55,696,000 -$2,846,910 $2.70 62
2022 Q2 21,419,836 $86,960,000 -$10,408,230 $4.06 65
2022 Q1 23,972,896 $102,126,074 -$3,479,215 $4.26 74
2021 Q4 24,042,241 $204,591,464 -$62,878,426 $8.51 80
2021 Q3 25,772,686 $525,252,762 -$13,482,057 $20.38 69
2021 Q2 25,886,732 $750,457,238 +$70,651,136 $28.99 66
2021 Q1 23,449,036 $682,731,224 -$1,668,878 $29.24 55
2020 Q4 22,309,276 $1,151,016,672 +$1,151,016,672 $52.41 58
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .